Small Cap Feast
Small Cap Feast – 22 March 2019
Set Menu AIM:
Total number of AIM Companies (Incl Susp): 905
Total number of AIM Companies trading: 835*
* As at 11 March 2019
Set Menu NEX Growth:
Total number of NEX Growth Market Companies (Incl Susp): 89*
Total number of NEX Growth Market Companies trading: 87*
* As at 11 March 2019
Set Menu Standard List:
Total number of Standard List Companies (Incl Susp): 161*
Total number of Standard List Companies trading: 142*
* As at 11 March 2019
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
What’s Cooking in the IPO Kitchen?
Main Market (Premium)
US Solar Fund, a newly-established investment company focused on investing in solar power assets mainly in the US, looking to raise $250m at $1. Expected 16 April
Network International Holdings—Pleading enabler of digital commerce across the Middle East and Africa region, operating across over 50 highly underpenetrated payment markets that contain a total population of 1.5 bn. 2018 rev $298m, underlying EBITDA $152m. Due April. No new funds to be raised. Secondary sell down. Targeting 25% of at least 25%.
Techniplas –global producer and support services company providing highly engineered and technically complex components, making the supply chain to original equipment manufacturers more efficient. FYDec17 rev $515m.
RenalytixAI (RENX.L) 137.50p £74m
The developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today the formation of the core investigator group to support clinical and regulatory pathways for a portfolio of advanced diagnostic and prognostic solutions in kidney transplant known collectively as FractalDx.
Products under development from FractalDx are anticipated to be part of the extended RenalytixAI pipeline following the introduction of KidneyIntelX in 2019 for the diagnosis of fast-progressing chronic kidney disease. RenalytixAI hopes to commercialise a range of advanced diagnostic tests that are expected to aid in accurate dosing of immune-suppression therapy and in making significant improvements in the identification of and monitoring for kidney transplant rejection.
Intosol* (INTO.L) 35.00p £4.30m
The award-winning international luxury travel company, has signed a five-year management contact, adding SOUL on the Heads, a luxury six-suite operating hotel located in Knysna in the Garden Route in South Africa, to its SOUL Private Collection (www.soulprivatecollection.com) of owned and manged boutique hotels. The Contract, subject to a profit share agreement, strengthens INTOSOL’s portfolio following the recent addition of SOUL Rainbow’s End and provides an additional revenue stream for the Company. “Since our IPO in October 2018, we have delivered on our strategy to increase revenues and margins through bolstering our SOUL Private Collection of owned and managed boutique hotels. In line with this, we have added three luxury properties to our portfolio and are confident that they will have a significant impact on the long-term profitability of the Company.”
FireAngel (FA..L) 19.50p £8.73m
One of Europe’s leading developers and suppliers of home safety products, announces that it is to supply smoke and heat alarms to a further housing association in Scotland.
FireAngel will supply Falkirk-based Link Group with the Group’s wireless interlinked mains-powered and battery-powered smoke and heat alarms.
The agreement with Link Group, that manages 10,000 properties, is the latest in a series of related wins for FireAngel, follows the requirement from 1 February 2019, for greater safety standards as part of the Housing (Scotland) Act.
Live Company Group (LVCG.L) 56.50p £40.51m
Three year licence agreement with PALEXPO SA (“PALEXPO”) to promote, manage and operate an annual BRICKLIVE show in Palexpo, Geneva, Switzerland (the “Agreement”). Palexpo is a convention centre in Geneva, Switzerland, which hosts numerous events including the Geneva Motor Show.
This will be the Group’s first BRICKLIVE show to be held in Geneva. Under the terms of the Agreement, PALEXPO will deliver one show per annum up until the end of 2021, with the Group receiving an annual licence fee. The first BRICKLIVE Show will be held at the end of October 2019 and will feature BRICKLIVE Ocean as the centre piece, which is the Group’s newest addition to its touring assets.
Starcom (STAR.L) 1.27p £3.67m
The Specialist in the development of wireless solutions for the remote tracking, monitoring and protection of a variety of assets, updated on the agreement with WIMC Solutions Inc for the sale of Tetis units. To date, WIMC has placed orders for only 1,500 Tetis units under this agreement and these were delivered to WIMC during 2018. Although this number of units is less than previously indicated, following successful testing of the Tetis units in the field and acceptance by end customers, the Company has entered into a replacement agreement. There is no obligation for WIMC to order any units under the agreement and therefore there is no guarantee that WIMC will ultimately order the maximum number of units indicated under the new agreement, but WIMC has indicated that it expects order levels for 2019 to be up to 3,400 units, which would have an aggregate value of up to US$660k.
Solo Oil (SOLO.L) 1.32p £8.69m
Strategy update: Solo is seeking to assemble a balanced, full lifecycle portfolio comprised of production, development and exploration assets that provide a sustainable path for growth alongside funded G&A. Net production target of at least 5,000 boepd within the next three years.
- Transition to an operating company to provide Solo greater control over the outcome of its investment decisions;
- Disciplined investment strategy to be delivered by capital efficient transactions;
- Transition to an operating company
- Strong pipeline of deal flow – Solo has recently evaluated more than 15 target acquisitions across a number of geographies and the Company remains active in a number of ongoing processes
Maistro (MAIS.L) 1.25p £5.21m
FY Dec 18 results from the UK-based company which provides an online marketplace for businesses seeking vetted service providers. Revenue up 154% to £1.5m. The adjusted EBITDA loss increased 1% to £2.11m (2017: £2.08m) due to increased investment in business development activities which has significantly contributed to the revenue growth in 2018. Cash of £1.1m. AI, Supplier Onboarding and Vetting and workflow improvements have been the main additions in 2018. “The roadmap for 2019 will continue to further refine these themes with the ultimate objective of moving towards a “Self-Serve” offering for lower value commodity projects. For higher value complex projects Maistro will continue to utilise the PaaS Platform for sourcing the right supplier but with the added managed service offering of a “human in the loop”. This combination of technology and managed services has been a key element to our success in 2018 with large global Enterprise customers.”
Reabold Resources (RBD.L) 0.62p £22.94m
Reabold is pleased to announce that Integrity Management Solutions has commenced drilling operations at the Burnett 2B well within the Monroe Swell field, onshore California, in which Reabold expects to earn a 50 per cent. equity interest. The drilling of Burnett 2B follows the successful Burnett 2A well drilled on the Monroe Swell field, as announced on 11 March 2019. Following the Burnett 2A drilling results, Reabold and IMS, made the decision to seek accelerated permitting for the Burnett 2B well, which was successful. The drilling rig was retained at Monroe Swell and, accordingly, is now drilling the 2B well. Assuming success at Burnett 2B, both wells at Monroe Swell will be tested following the completion of drilling activities and put onto production shortly after. Following the drilling and completion of Burnett 2B, Reabold will have completed its earn-in to the Monroe Swell licence area and will be assigned a 50 per cent. equity interest.
KCOM (KCOM.L) 70.00p £361.62m
The Group will announce the results of a review of group strategy on 26 April 2019, instead of on 27 March 2019. Graham Sutherland (CEO) and Anna Bielby (CFO) will present their strategy which follows on from Graham’s appointment in October last year.
The Group confirms trading and net debt remains in line with market expectations for the financial year ending 31 March 2019. As previously stated, the Board expects to propose a final dividend for the year of not less than 2p per share.
Oxford Instruments (OXIG.L) 1,020.00p £585.23m
The provider of high technology products and systems for industry and research, today announces winning the global tender to supply its market leading cryogenic equipment to the Institute of Physics-Chinese Academy of Sciences.
“This is an excellent example of the growth we are seeing from customers involved in Physical Science Research and Quantum Technologies where our key enabling technologies and advanced solutions enable fundamental research and accelerate our customers applied R&D.”
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email email@example.com with “unsubscribe me”.